Abeona Therapeutics
ABEO
78 hedge funds and large institutions have $35.3M invested in Abeona Therapeutics in 2020 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 32 reducing their positions, and 15 closing their positions.
210% more call options, than puts
Call options by funds: $65K | Put options by funds: $21K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.38% less ownership
Funds ownership: 2.08% → 1.7% (-0.38%)
6% less funds holding
Funds holding: 83 → 78 (-5)
33% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 15
44% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 32
72% less capital invested
Capital invested by funds: $126M → $35.3M (-$91.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Verition Fund Management
Greenwich,
Connecticut
|
+$1.87M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$324K |
| 3 |
Los Angeles Capital Management
Los Angeles,
California
|
+$254K |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$243K |
| 5 |
JP Morgan Chase
New York
|
+$223K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$8.37M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$4.64M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.21M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.06M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.38M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
76
Hudson Bay Capital Management
Stamford,
Connecticut
| – | -$1.38M | -19,000 | Closed |
|
77
Two Sigma Investments
New York
| – | -$255K | -3,506 | Closed |
|
78
Assenagon Asset Management
Senningerberg,
Luxembourg
| – | -$217K | -2,980 | Closed |
|
79
SG Americas Securities
New York
| – | -$189K | -2,588 | Closed |
|
80
Two Sigma Advisers
New York
| – | -$132K | -1,816 | Closed |
|
81
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$99K | -1,358 | Closed |
|
|
AGM
82
Alpine Global Management
New York
| – | -$73K | -1,000 | Closed |
|
|
CSS
83
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$25K | -336 | Closed |
|
|
PAM
84
Panagora Asset Management
Boston,
Massachusetts
| – | -$11K | -145 | Closed |
|
|
PAG
85
Private Advisor Group
Morristown,
New Jersey
| – | -$3K | -46 | Closed |
|
86
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$1K | -17 | Closed |
|
|
BWM
87
Baystate Wealth Management
Boston,
Massachusetts
| – | +$126 | +2 | New |
|
ABEO Hedge Fund Activity: Q3 2020 in Review
78 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q3 2020, worth a combined $35.3M — down 72% from $126M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of ABEO and 10 opened new positions — a net loss of 5 holders — while 32 trimmed existing stakes and 18 added.
The largest buyer was Verition Fund Management, opening a new position worth an estimated $1.87M. The largest seller was Great Point Partners, cutting an estimated $8.37M.
- 78 institutional investors held Abeona Therapeutics (ABEO) as of Q3 2020, down from 83 in Q2 2020.
- Funds reported $35.3M of Abeona Therapeutics stock for Q3 2020, down 72% quarter-over-quarter.
- 10 funds opened new Abeona Therapeutics positions in Q3 2020 and 15 closed out, a net change of -5 holders.
- The largest Abeona Therapeutics buyer in Q3 2020 was Verition Fund Management, an estimated $1.87M added.
- The largest Abeona Therapeutics seller in Q3 2020 was Great Point Partners, an estimated $8.37M sold.
Based on aggregated 13F filings for Q3 2020.